Delivery Order SPE2DB22D1017-SPE2DB25FG6ZE
Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,062.34, is for the delivery of Multaq 400 mg tablets over a period ending on May 6, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Multaq 400 mg tablets, a medication used to treat certain heart rhythm disorders. The contract has a ceiling value of $3,870.92 and a period of performance through May 2, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is for the supply of Multaq 400 mg tablets, a medication used to treat certain types of heart rhythm disorders. The contract has a ceiling value of $19,629.76 and a performance period ending on May 4, 2023. The contract was awarded on a firm fixed-price basis and does not have a set-aside designation,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Multaq 400 mg tablets, a cardiovascular medication, and has a ceiling value of $1,499.13. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,161.50 contract provides the DLA with 4,563,399,610 units of the prescription drug Multaq 400 mg tablet. The order has an ultimate completion date of January 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,460.37, is for the delivery of Multaq 400 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,589.64, is for the supply of 4,568,055,135 units of the prescription medication Multaq 400 mg tablets. The contract has an ultimate completion date of April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,997.51 contract is for the supply of Multaq 400 mg tablets, a prescription drug used to treat certain heart rhythm disorders. The contract has an ultimate completion date of January 13, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Multaq 400 mg tablets, a cardiovascular medication, with a ceiling value of $3,712.09 and a period of performance through April 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,107.95 firm fixed-price contract is for the delivery of Multaq 400 mg tablets, a cardiovascular medication, with a performance period through September 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...